EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Clinical and Genetic Analysis of L-2-Hydroxyglutaric Aciduria Caused by a Novel L2HGDH Mutation with a Concurrent RYR1 Variant

Zahra Beyzaei iD, Seyed Mohsen Dehghani, Bita Geramizadeh, Ralf Weiskirchen iD

Genes · 26.06.2026 · 17 (7) · 735

DOI: 10.3390/genes17070735 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, online erschienen am 26.06.2026. Verfasst von Zahra Beyzaei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz 7193711351, Iran. Hauptthemen laut MEDLINE: Alcohol Oxidoreductases, Brain Diseases, Metabolic, Inborn, Ryanodine Receptor Calcium Release Channel. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: L-2-hydroxyglutaric aciduria (L2HGA) is a rare autosomal recessive neurometabolic disorder marked by developmental delay, intellectual disability, and progressive movement abnormalities. Variants in RYR1 can cause congenital myopathies, but data on the co-occurrence of variants in populations are limited. The aim of this study was to characterize the clinical and genetic basis of the neurometabolic and neuromuscular abnormalities and to investigate the potential interaction between the identified variants.

Methods

Patients with complex, previously undiagnosed clinical presentations underwent neurological evaluation, including brain magnetic resonance imaging, electromyography, biochemical testing, and whole-exome sequencing (WES). Identified variants were analyzed in silico and confirmed by Sanger sequencing in the patient and her parents. Three cases were reviewed, and one of these patients exhibited developmental delay, hypotonia, intellectual disability, and progressive motor dysfunction. Biochemical tests revealed markedly elevated urinary 2-hydroxyglutaric acid levels, consistent with L2HGA.

Results

WES identified a homozygous likely pathogenic variant in L2HGDH (c.589_590insGGC, p.Q197insG), confirming the molecular diagnosis of L2HGA. In addition, a heterozygous missense variant in RYR1 (c.7268T>A, p.M2423K), classified as a variant of uncertain significance, was detected and was inherited from her mildly affected father. The L2HGDH variant explains the neurometabolic phenotype of the patient, whereas the RYR1 variant remains of uncertain significance, and its clinical contribution cannot be clearly established.

Conclusions

To our knowledge, this case illustrates the co-occurrence of a likely pathogenic L2HGDH variant and a heterozygous RYR1 variant of uncertain significance. The findings expand the mutational spectrum of L2HGA and underscore the value of comprehensive genomic testing in complex neurometabolic and neuromuscular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol OxidoreductasesBrain Diseases, Metabolic, InbornRyanodine Receptor Calcium Release ChannelChildFemaleHumansMaleExome SequencingIntellectual DisabilityMutationPedigree

Stichwörter der Autor:innen

L-2-hydroxyglutaric aciduriaL2HGDHRYR1exome sequencingnovel mutations

Substanzen

Alcohol OxidoreductasesL2HGDH protein, humanRyanodine Receptor Calcium Release ChannelRYR1 protein, human

Autor:innen und Institutionen

  • Shiraz Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz 7193711351, Iran.
  • Gastroenterology and Hepatology Research Center, Shiraz University of Medical Sciences, Shiraz 7193711351, Iran.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC) RWTH University Hospital Aachen, D-52074 Aachen, Germany.

ORCID-Profile: Zahra Beyzaei, Ralf Weiskirchen

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Beyzaei, Z., Dehghani, S. M., Geramizadeh, B., & Weiskirchen, R. (2026). Clinical and Genetic Analysis of L-2-Hydroxyglutaric Aciduria Caused by a Novel L2HGDH Mutation with a Concurrent RYR1 Variant. Genes, 17(7), 735. https://doi.org/10.3390/genes17070735

Vancouver

Beyzaei Z, Dehghani SM, Geramizadeh B, Weiskirchen R. Clinical and Genetic Analysis of L-2-Hydroxyglutaric Aciduria Caused by a Novel L2HGDH Mutation with a Concurrent RYR1 Variant. Genes. 2026;17(7):735. doi:10.3390/genes17070735

BibTeX
@article{Beyzaei2026,
  author = {Beyzaei, Zahra and Dehghani, Seyed Mohsen and Geramizadeh, Bita and Weiskirchen, Ralf},
  title = {Clinical and Genetic Analysis of L-2-Hydroxyglutaric Aciduria Caused by a Novel L2HGDH Mutation with a Concurrent RYR1 Variant},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {735},
  doi = {10.3390/genes17070735}
}
Kostenlos starten →